APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health – study protocol paper for a phase III multicentre, open-label randomised controlled trial
APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health – study protocol paper for a phase III multicentre, open-label randomised controlled trial
Catherine Parbutt, Rovel Colaco, N.G. Burnet, Meredith Louise Borland et al.
Citations
5 citations
Journal
BMJ Open
Topics
Glioma Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
8.13
article
APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health – study protocol paper for a phase III multicentre, open-label randomised controlled trial
Catherine Parbutt, Rovel Colaco, N.G. Burnet, Meredith Louise Borland, J. Lilley, Daniel Egleston, Samantha Noutch, Helen Bulbeck, Daniel O’Hara, Robert Douglas Murray, Florien Willemijn Boele, M C Norris, Sarah Brown, Gillian Whitfield, Stuart Currie, Finbar Slevin, Eleanor Hudson, Naomi Fersht, A. M. Bruce, Susan C Short, Matthew Lowe, Louise Murray, Yen Ching Chang, Elizabeth Miles, Martin Klein, Alexandra Smith, J.R. Powell, Charlotte A. Smith
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(2)
Institutions
University of Leeds (GB), Entrust (GB), University College London Hospitals NHS Foundation Trust (GB), Velindre NHS Trust (GB), Leeds Teaching Hospitals NHS Trust (GB), Manchester Academic Health Science Centre (GB), Mount Vernon Hospital (GB), Clatterbridge Cancer Centre NHS Foundation Trust (GB), The Christie NHS Foundation Trust (GB), Lincolnshire Partnership NHS Foundation Trust (GB), Amsterdam University Medical Centers (NL), University College London (GB), University of Glasgow (GB), Vrije Universiteit Amsterdam (NL)
Funders
Cancer Research UK, National Institute for Health and Care Research, Department of Health and Social Care, University of Leeds, Medical Research Council, Efficacy and Mechanism Evaluation Programme